Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 2/2021

01-04-2021 | Transesophageal Echocardiography | Original Article

Percutaneous closure of residual atrial septal defect after surgical closure

Authors: Soichiro Ogura, Yoichi Takaya, Teiji Akagi, Koji Nakagawa, Hiroshi Ito

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2021

Login to get access

Abstract

Residual atrial septal defect (ASD) after surgical closure is rare, but some cases are seen during follow-up period. Redo surgery for residual ASD is often declined, while percutaneous closure can be acceptable. However, the indication of percutaneous closure for residual ASD has not been established. We reviewed our experience with percutaneous closure of residual ASD using medical and procedural records. Between 2006 and 2018, residual ASD was seen in seven patients. The median age of patients was 66 years (range 50–81 years), and the median period after surgical closure of ASD was 39 years (range 13–48 years). All patients had symptoms related to ASD. Percutaneous closure of residual ASD was successfully performed in all seven patients. No residual shunts were detected during the median follow-up period of 4.2 years (range 0.5–11 years) after percutaneous closure. Based on transesophageal echocardiographic findings and operative records for surgical closure, we considered two mechanisms causing residual ASD, such as the tear of surgical suture line and the overlooking of defect during surgical closure. Percutaneous closure of residual ASD was safely performed without any complications, suggesting that percutaneous is an effective therapeutic strategy for residual ASD after surgical closure.
Literature
1.
go back to reference Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27–32 years. N Engl J Med. 1990;323:1645–50.CrossRef Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27–32 years. N Engl J Med. 1990;323:1645–50.CrossRef
2.
go back to reference Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grownup congenital heart diseases (new version 2010). Eur Heart J. 2010;31:2915–57.CrossRef Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grownup congenital heart diseases (new version 2010). Eur Heart J. 2010;31:2915–57.CrossRef
3.
go back to reference Chessa M, Butera G, Giamberti A, Bini RM, Carminati M. Transcatheter closure of residual atrial septal defects after surgical closure. J Inetrv Cardiol. 2002;15:187–9.CrossRef Chessa M, Butera G, Giamberti A, Bini RM, Carminati M. Transcatheter closure of residual atrial septal defects after surgical closure. J Inetrv Cardiol. 2002;15:187–9.CrossRef
Metadata
Title
Percutaneous closure of residual atrial septal defect after surgical closure
Authors
Soichiro Ogura
Yoichi Takaya
Teiji Akagi
Koji Nakagawa
Hiroshi Ito
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2021
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-020-00671-5

Other articles of this Issue 2/2021

Cardiovascular Intervention and Therapeutics 2/2021 Go to the issue